Sensodyne maker Haleon slips as sales growth concerns overshadow profit beat
By Raechel Thankam Job and Richa Naidu July 30 (Reuters) - Sluggish European demand and weak respiratory sales raised doubts on Thursday about whether Haleon can meet its sales targets, sending shares in the consumer health company lower despite better-than-expected first-half profit. 
